Senate cuts follow-on biologics tax cut
Executive Summary
The Senate version of recently introduced follow-on biologics legislation, the "Access to Life-Saving Medicine Act" (1S 4016), unlike the House bill, does not include a tax credit for studies performed to demonstrate interchangeability. According to the office of Sen. Hillary Clinton (D-N.Y.), the provision was omitted to avoid a joint referral to the Finance Committee in addition to the Health Committee. Renewal of the Prescription Drug User Fee Act will be under the Health Committee, and Clinton's office believes PDUFA could be a vehicle for follow-on biologics legislation...